Detalles de la búsqueda
1.
Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.
Clin Infect Dis
; 2023 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38035791
2.
Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study.
Vaccine
; 42(7): 1768-1776, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38368226
3.
Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.
medRxiv
; 2023 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37645896
Resultados
1 -
3
de 3
1
Próxima >
>>